| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/24/2013 | WO2013156782A1 3- (1' -adamantyl) - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1h - 2 - benzopyran for use in the treatment of a disease associated with beta-amyloid induced toxicity |
| 10/24/2013 | WO2013156614A1 Methods for treating parkinson's disease |
| 10/24/2013 | WO2013156505A1 Agents for treating disorders involving modulation of ryanodine receptors |
| 10/24/2013 | WO2013156329A1 Estrogenic components for use in the treatment of neurological disorders. |
| 10/24/2013 | WO2013156232A1 Use of benzofuranylsulfonates in neuropathic pain |
| 10/24/2013 | WO2013156231A1 Use of imidazotriazinones in neuropathic pain |
| 10/24/2013 | WO2013156035A1 Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| 10/24/2013 | WO2013155716A1 Capsule to improve sleep |
| 10/24/2013 | WO2013155714A1 Heart rejuvenating capsule |
| 10/24/2013 | WO2013155586A1 Process for preparing inclusion compounds enclosing cyclodextrins and drugs, using a continuous-flow system |
| 10/24/2013 | WO2013130150A9 Metalloporphyrin neurological treatments |
| 10/24/2013 | WO2013091883A3 Selective ligands for the angiotensin ii receptors |
| 10/24/2013 | WO2013022846A3 Flavonoid compounds |
| 10/24/2013 | US20130281705 Compounds for the treatment of metabolic disorders |
| 10/24/2013 | US20130281522 Methods for alzheimer's disease treatment and cognitive enhancement |
| 10/24/2013 | US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 10/24/2013 | US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 10/24/2013 | US20130280348 Carbon dioxide and saline nasal delivery methods and treatments |
| 10/24/2013 | US20130280330 Microsphere drug carrier, preparation method, composition and use thereof |
| 10/23/2013 | EP2653473A1 Fused Aminodihydro-Oxazine Derivatives |
| 10/23/2013 | EP2653469A1 Pyrazole derivative |
| 10/23/2013 | EP2653466A1 Agents for treating disorders involving modulation of ryanodine receptors |
| 10/23/2013 | EP2653465A1 Opioid receptor modulators |
| 10/23/2013 | EP2653168A1 Therapeutic agent for disc herniation |
| 10/23/2013 | EP2653163A1 Estrogenic components for use in the treatment of neurological disorders |
| 10/23/2013 | EP2653158A1 Therapeutic agent for blood-brain barrier disruption syndrome |
| 10/23/2013 | EP2653157A1 Astaxanthin for improving muscle atrophy |
| 10/23/2013 | EP2653152A1 Pharmaceutical compositions for sublingual delivery of opioids |
| 10/23/2013 | EP2651970A1 Serum amyloid p protein |
| 10/23/2013 | EP2651929A1 Novel benzofurane compounds |
| 10/23/2013 | EP2651888A1 New compounds for the treatment of neurodegenerative diseases |
| 10/23/2013 | EP2651887A1 Novel compounds for the treatment of neurodegenerative diseases |
| 10/23/2013 | EP2651451A1 Treatment of spinal cord injury and traumatic brain injury using placental stem cells |
| 10/23/2013 | EP2651435A1 Method for suppressing an immune response |
| 10/23/2013 | EP2651429A2 Neuropeptide analogs, compositions, and methods for treating pain |
| 10/23/2013 | EP2651407A2 3-methanesulfonylpropionitrile for treating inflammation and pain |
| 10/23/2013 | EP2651406A1 Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields |
| 10/23/2013 | EP2651405A2 Casein kinase 1 (ck1 ) inhibitors |
| 10/23/2013 | EP2651404A2 Casein kinase 1delta (ck1delta) inhibitors |
| 10/23/2013 | EP2651391A1 Pharmaceutical composition for oral administration intended to prevent misuse |
| 10/23/2013 | EP2651390A1 Zolpidem-based orodispersible pharmaceutical tablet |
| 10/23/2013 | EP2651389A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them |
| 10/23/2013 | EP2651222A1 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors |
| 10/23/2013 | CN103370338A Myomegalin variant 8 and uses thereof |
| 10/23/2013 | CN103370331A Amino statin derivatives for the treatment of arthrosis |
| 10/23/2013 | CN103370289A 4-hydroxybutyric acid deuterated analogs |
| 10/23/2013 | CN103370074A Sense-improving agent |
| 10/23/2013 | CN103370059A A drug delivery device |
| 10/23/2013 | CN103361427A Application of miRNA-219 (micro-ribonucleic acid) compound to preparation of marker for diagnosing chronic pain and medicament for treating chronic pain |
| 10/23/2013 | CN103361290A Application of composition of bacillus subtilis BS01 and ganoderma lucidum spore powder in improving sleep |
| 10/23/2013 | CN103360456A Triterpenoid compounds, and preparation and application thereof |
| 10/23/2013 | CN103360451A Preparation of cucurbitacin compounds and application of cucurbitacin compounds to medicines |
| 10/23/2013 | CN103360388A 5-Amino-1,4-dihydro-1,8-naphthyridine derivatives and pharmaceutical compositions as well as uses thereof |
| 10/23/2013 | CN103360371A (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts |
| 10/23/2013 | CN103360342A 3-Cyanoaniline alkyl aryl piperazine derivative and application in preparing medicaments |
| 10/23/2013 | CN103360305A Substituted aryl piperazine aralkyl ketone derivative and application of derivative in preparing analgesic |
| 10/23/2013 | CN103360276A Crystal form, preparation method and application of agomelatine, as well as medicine composition |
| 10/23/2013 | CN103357018A Nerve injury-resistant effect of cyclooxygenase (COX) inhibitor enhanced rho kinase inhibitor |
| 10/23/2013 | CN103357006A Extractive and preparation containing same |
| 10/23/2013 | CN103356978A Ossa draconis intelligence improving pill |
| 10/23/2013 | CN103356966A Traditional Chinese medicine for treating migraine |
| 10/23/2013 | CN103356941A Health-care medicinal liquor having a plurality of functions |
| 10/23/2013 | CN103356906A Traditional Chinese medicine preparation for caring insomniac and preparation method |
| 10/23/2013 | CN103356904A Gastrodia elata wine and preparation method thereof |
| 10/23/2013 | CN103356883A Heat-clearing and dampness-eliminating medicine and preparation method thereof |
| 10/23/2013 | CN103356881A Qi-invigorating and blood-nourishing chewing tablets and preparation method thereof |
| 10/23/2013 | CN103356877A Traditional Chinese medicine composition for treating orthopedic diseases |
| 10/23/2013 | CN103356874A Topical ointment for treating prosopoplegia and preparation method thereof |
| 10/23/2013 | CN103356867A Heat-clearing, detoxifying, anti-inflammatory and analgesic drug |
| 10/23/2013 | CN103356863A Aerosol spray for treating cervical spondylosis |
| 10/23/2013 | CN103356841A Traditional Chinese medicine composition for treating abdominal epilepsy |
| 10/23/2013 | CN103356796A Blood stasis removing particles and preparation method thereof |
| 10/23/2013 | CN103356790A Spleen-strengthening and qi-benefiting oral liquid and preparation method thereof |
| 10/23/2013 | CN103356789A Zanthoxylum armatum total alkaloids extract, and preparation method and application thereof |
| 10/23/2013 | CN103356766A Traditional Chinese medicine for improving sleep quality |
| 10/23/2013 | CN103356752A Corydalisdecumbens(Thunb.)Pers. injection and preparation method thereof |
| 10/23/2013 | CN103356731A Xuesaitong tablet containing eucommia extract and panax notoginseng saponins and application thereof |
| 10/23/2013 | CN103356713A Acupoint sticking therapy externally-applied traditional Chinese medicinal plaster for treating peripheral facial paralysis, and preparation method thereof |
| 10/23/2013 | CN103356710A Treatment of diseases and disorders using placental stem cells |
| 10/23/2013 | CN103356704A Method for preparing medicine used for curing ulceration caused by diabetic neuropathy |
| 10/23/2013 | CN103356664A Brain atrophy prevention agent |
| 10/23/2013 | CN103356656A Application of Chukrasone A in preparing medicines for treating Alzheimer disease |
| 10/23/2013 | CN103356620A Novel use of bisbenzylisoquinoline compounds or pharmaceutically acceptable salts thereof in treating or improving depressive symptom |
| 10/23/2013 | CN103356610A Application of tetrahydrocorysamine in preparation of medicine for treating senile dementia |
| 10/23/2013 | CN103356599A Application of Chukrasone B in antidepressant medicines |
| 10/23/2013 | CN103356591A Application of Chukrasone B in preparation of medicines for treating Alzheimer disease |
| 10/23/2013 | CN103356558A Application of Sarcaboside A in preparation of drug for treating alzheimer disease |
| 10/23/2013 | CN103356528A Application of Sarcaboside A in antidepressant medicine |
| 10/23/2013 | CN103356522A Application of Sarcaboside B in preparation of medicines for treating alzheimer disease |
| 10/23/2013 | CN103356521A Application of butylphthalide or derivatives thereof in preparation of medicaments for treating or preventing radiation brain damage |
| 10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/23/2013 | CN103356513A Applications of delta-elemene and derivative thereof in anti-atherosclerosis |
| 10/23/2013 | CN103356509A Film agent containing zolpidem serving as main active component |
| 10/23/2013 | CN103356501A Risperidone tablet and preparation method thereof |
| 10/23/2013 | CN103356015A Functional mint pillow |
| 10/23/2013 | CN103071003B Traditional Chinese medicine for promoting blood circulation, removing blood stasis and clearing and activating channels and collaterals |
| 10/23/2013 | CN102872052B Application of gypensapogenin B to Alzheimer disease treatment drugs |
| 10/23/2013 | CN102872050B Application of gypensapogenin A to Alzheimer disease treatment drugs |
| 10/23/2013 | CN102872048B Application of gypensapogenin B to ischemic brain injury treatment drugs |
| 10/23/2013 | CN102813839B Compound medicine for treating cluster headache syndrome |